EQS-News: MorphoSys AG / Key word(s): Quarterly / Interim StatementMorphoSys AG Reports First Quarter 2024 Financial Results 29.04.2024 / 22:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, April 29, 2024 MorphoSys AG Reports First Quarter 20...

Related Keywords

Planegg , Bayern , Germany , Canada , Massachusetts , United States , Boston , Austria , America , German , American , Monjuvi Minjuvi , Julia Neugebauer , Eamonn Nolan , Jean Paul Kress , Thomas Biegi , Linkedin , Distribution Services , Incyte Corporation , Twitter , Morphosys Group Key Figures , Corporate Affairs , Novartis , Drug Administration , European Medicines Agency , American Society Of Clinical Oncology , German Federal Financial Supervisory Authority The Bafin , Lymphoma Society , Company Annual Report On Form , Constellation Pharmaceuticals Inc , Group Revenues , Exchange Commission , Share Of Loss Associates , Additional Group , Xencor Inc , Nasdaq , Development Rd Expenses , Corporate Communications Investor Relations , Interim Statement , First Quarter , Business Combination Agreement , Management Board , Supervisory Board , Chief Executive Officer , Public Takeover Offer Highlights , Novartis Bidco , Morphosys Management Board , Conferences Highlights , Clinical Oncology , Net Loss , Discontinued Operations , New Drug Application , Marketing Authorization Application , Sys Group Key Figures , Impairment Losses , Tax Benefit , Net Profit , Investor Relations , Morphosys Investor Relations , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Prescribing Information , German Federal Financial Supervisory Authority , American Depositary Shares , Tender Offer Statement , Takeover Offer , Takeover Offer Documents , German Securities Acquisition , Takeover Act , Recommendation Statement , Recommendation Statements , Annual Report , Vice President , Global Investor , Corporate Communications , Corporate News , Regulatory Announcements ,